Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Demonstration and Dissemination Projects (R18)
Project #
3R18HS007357-04S1
Application #
2236039
Study Section
VA Health Services Research and Development Scientific Merit Review Board (HSRD)
Project Start
1992-09-01
Project End
1997-08-31
Budget Start
1995-09-01
Budget End
1997-08-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Harvard University
Department
Other Health Professions
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Majumdar, S R; Inui, T S; Gurwitz, J H et al. (2001) Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. J Gen Intern Med 16:351-9
Soumerai, S B; McLaughlin, T J; Gurwitz, J H et al. (1999) Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance. Arch Intern Med 159:2013-20
McLaughlin, T J; Gurwitz, J H; Willison, D J et al. (1999) Delayed thrombolytic treatment of older patients with acute myocardial infarction. J Am Geriatr Soc 47:1222-8
Majumdar, S R; Gurwitz, J H; Soumerai, S B (1999) Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med 14:711-7
Willison, D J; Soumerai, S B; McLaughlin, T J et al. (1998) Consultation between cardiologists and generalists in the management of acute myocardial infarction: implications for quality of care. Arch Intern Med 158:1778-83
McLaughlin, T J; Soumerai, S B; Willison, D J et al. (1997) The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med 12:1-6
Gurwitz, J H; McLaughlin, T J; Willison, D J et al. (1997) Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med 126:593-9
Soumerai, S B; Lipton, H L (1995) Computer-based drug-utilization review--risk, benefit, or boondoggle? N Engl J Med 332:1641-5